Oxytetracycline HCl (Pharma Grade)

Product Overview

Oxytetracycline Hydrochloride is a first-generation broad-spectrum tetracycline antibiotic with an extensive history of clinical use spanning over six decades. It acts by binding to the 30S ribosomal subunit, reversibly inhibiting bacterial protein synthesis. Its spectrum covers Gram-positive and Gram-negative bacteria, as well as Rickettsia spp., Chlamydia spp., and Mycoplasma spp.

This pharmaceutical-grade Oxytetracycline HCl meets BP, EP, and USP pharmacopoeia requirements and is suitable for a range of human pharmaceutical dosage forms. Its well-characterized safety profile and broad antimicrobial spectrum continue to make it a relevant API for diverse therapeutic applications including respiratory infections, dermatological conditions, and specific zoonotic diseases.

Quality Specifications

Purity	As per BP/EP/USP monograph
Residual Solvents	Compliant with ICH Q3C
Heavy Metals	Compliant with pharmacopoeia limits
GMP Status	Manufactured under GMP conditions

Pharmaceutical Applications

Therapeutic Indications

• Respiratory Tract Infections: Community-acquired pneumonia, bronchitis caused by susceptible organisms
• Acne Vulgaris: Oral and topical formulations for moderate to severe acne
• Chlamydia & STIs: Treatment of urogenital chlamydia infections and lymphogranuloma venereum
• Brucellosis: In combination with streptomycin for brucellosis treatment
• Rickettsial Infections: Rocky Mountain spotted fever, typhus, and other rickettsial diseases